Showing results (371-380 of 498) with videos related to

Sort By:
Pageof 50
Blood Cancer Journal|August 18, 2022
Outcomes of renal transplantation in patients with AL amyloidosis: an international collaboration through The International Kidney and Monoclonal Gammopathy Research GroupAndrea Havasi, Cihan Heybeli, Nelson Leung, et al.
Veterinary Pathology|June 12, 2024
Renal alterations in cats (Felis catus) housed in shelters and affected by systemic AA-amyloidosis: Clinicopathological data, histopathology, and ultrastructural featuresFilippo Ferri, Silvia Ferro, Silvia Lucia Benali, et al.
Journal of Neurology|September 6, 2022
Muscle quantitative MRI as a novel biomarker in hereditary transthyretin amyloidosis with polyneuropathy: a cross-sectional studyElisa Vegezzi, Andrea Cortese, Niels Bergsland, et al.
Nature Communications|July 28, 2024
Helical superstructures between amyloid and collagen in cardiac fibrils from a patient with AL amyloidosisTim Schulte, Antonio Chaves-Sanjuan, Valentina Speranzini, et al.
Blood|June 27, 2023
Birtamimab plus standard of care in light-chain amyloidosis: the phase 3 randomized placebo-controlled VITAL trialMorie A Gertz, Adam D Cohen, Raymond L Comenzo, et al.
European Journal of Clinical Investigation|May 13, 2021
Quality of life assessment in amyloid transthyretin (ATTR) amyloidosisAlberto Aimo, Claudio Rapezzi, Federico Perfetto, et al.
Blood Cancer Journal|January 25, 2023
The management of light chain (AL) amyloidosis in Europe: clinical characteristics, treatment patterns, and efficacy outcomes between 2004 and 2018Giovanni Palladini, Stefan Schönland, Giampaolo Merlini, et al.
Frontiers in Cell and Developmental Biology|August 30, 2021
Opposite Roles for ZEB1 and TMEJ in the Regulation of Breast Cancer Genome StabilityMélanie K Prodhomme, Sarah Péricart, Roxane M Pommier, et al.
Leukemia Research|December 29, 2022
Ruxolitinib-induced reactivation of cytomegalovirus and Epstein-Barr virus in graft-versus-host diseaseDelphine Lebon, Adèle Dujardin, Alexis Caulier, et al.
The New England Journal of Medicine|January 25, 2002
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphomaBertrand Coiffier, Eric Lepage, Josette Briere, et al.
Pageof 50